RU2003110183A - METHOD FOR TREATING MULTIPLE SCLEROSIS - Google Patents

METHOD FOR TREATING MULTIPLE SCLEROSIS

Info

Publication number
RU2003110183A
RU2003110183A RU2003110183/14A RU2003110183A RU2003110183A RU 2003110183 A RU2003110183 A RU 2003110183A RU 2003110183/14 A RU2003110183/14 A RU 2003110183/14A RU 2003110183 A RU2003110183 A RU 2003110183A RU 2003110183 A RU2003110183 A RU 2003110183A
Authority
RU
Russia
Prior art keywords
multiple sclerosis
treating multiple
buttocks
lasting
week
Prior art date
Application number
RU2003110183/14A
Other languages
Russian (ru)
Inventor
Татьяна Всеволодовна Матвеева
Ирина Фаритовна Хафизова
Original Assignee
Казанский государственный медицинский университет
Filing date
Publication date
Application filed by Казанский государственный медицинский университет filed Critical Казанский государственный медицинский университет
Publication of RU2003110183A publication Critical patent/RU2003110183A/en

Links

Claims (1)

Способ лечения рассеянного склероза, включающий комплексную лекарственную терапию, отличающийся тем, что в качестве лекарственного средства дополнительно назначают иммуноглобулин человеческий нормальный внутримышечно в наружный квадрант ягодицы по 1,5 мл с частотой 2 раза в неделю, длительностью от одного до двух лет.A method of treating multiple sclerosis, including complex drug therapy, characterized in that the human normal immunoglobulin is additionally prescribed as a medicine in the outer quadrant of the buttocks of 1.5 ml with a frequency of 2 times a week, lasting from one to two years.
RU2003110183/14A 2003-04-09 METHOD FOR TREATING MULTIPLE SCLEROSIS RU2003110183A (en)

Publications (1)

Publication Number Publication Date
RU2003110183A true RU2003110183A (en) 2004-11-27

Family

ID=

Similar Documents

Publication Publication Date Title
NO20053077D0 (en) Therapeutic formulations for the treatment of beta-amyloid-related diseases.
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
ATE399553T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXTROMETHORPHAN AND QUINIDENE FOR THE TREATMENT OF NEUROLOGICAL DISEASES
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
EA200401319A1 (en) NEW HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR USE IN MEDICINE
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
BR0116653A (en) Medicinal product containing a polyamine as active substance
RU2003110183A (en) METHOD FOR TREATING MULTIPLE SCLEROSIS
EE200200549A (en) Split dose therapy with vascular damaging activity
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
WO2004053064A3 (en) Engineered fab'fragment anti-tumor necrosis factor alpha in combination with disease modifying anti-rheumatic drugs
WO2006032053A3 (en) Methods of treating symptoms of multiple sclerosis using vitamin d and related compounds
RS20050603A (en) New combinations and new application of pharmaceutically active compounds
RU2002113511A (en) A method for the treatment of odontogenic adenoflegmon
UA31379A (en) The method for treatment of coronary heart disease
RU2003127467A (en) METHOD FOR RESTORING TREATMENT OF PATIENTS WITH CHRONIC CHOLECYSTITIS
RU2004128121A (en) METHOD FOR TREATING SPINAL CORD INJURIES
RU2001129201A (en) A method for the treatment of chronic traumatic osteomyelitis complicated by a purulent-inflammatory process in the periandibular soft tissues
RU2004107473A (en) METHOD FOR THERAPY OF CHRONIC OVERSTRAINING OF AN ATHLETES
谢瑞丰 My Understanding about Treatment of Deficiency-Type Oropharyngeal Ulceration with Invigorating Method
RU2003124971A (en) METHOD FOR TREATING PATIENTS WITH NEUROTIC AND SOMATOFORM DISORDERS
RU2002107088A (en) METHOD FOR TREATING INFLAMMATORY EYE DISEASES
RU2004130974A (en) METHOD FOR TREATING INFLAMMATORY EYE REACTION